These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 24133966)

  • 1. [Recent progress in development of antibiotics against Gram-negative bacteria].
    Xu ZQ; Xu ZY
    Yao Xue Xue Bao; 2013 Jul; 48(7):993-1004. PubMed ID: 24133966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combating multidrug-resistant Gram-negative bacterial infections.
    Xu ZQ; Flavin MT; Flavin J
    Expert Opin Investig Drugs; 2014 Feb; 23(2):163-82. PubMed ID: 24215473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New aminoglycoside antibiotics.
    Dozzo P; Moser HE
    Expert Opin Ther Pat; 2010 Oct; 20(10):1321-41. PubMed ID: 20670208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC.
    Lemaître N; Liang X; Najeeb J; Lee CJ; Titecat M; Leteurtre E; Simonet M; Toone EJ; Zhou P; Sebbane F
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent Antibiotics Active against Multidrug-Resistant Gram-Negative Bacteria.
    Otsuka Y
    Chem Pharm Bull (Tokyo); 2020; 68(3):182-190. PubMed ID: 32115524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developments on antibiotics for multidrug resistant bacterial Gram-negative infections.
    Voulgaris GL; Voulgari ML; Falagas ME
    Expert Rev Anti Infect Ther; 2019 Jun; 17(6):387-401. PubMed ID: 31006284
    [No Abstract]   [Full Text] [Related]  

  • 7. Multidrug-resistant gram-negative organisms: a review of recently approved antibiotics and novel pipeline agents.
    Provenzani A; Hospodar AR; Meyer AL; Leonardi Vinci D; Hwang EY; Butrus CM; Polidori P
    Int J Clin Pharm; 2020 Aug; 42(4):1016-1025. PubMed ID: 32638294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and development of new antibacterial agents targeting Gram-negative bacteria in the era of pandrug resistance: is the future promising?
    Page MG; Bush K
    Curr Opin Pharmacol; 2014 Oct; 18():91-7. PubMed ID: 25277839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect?
    Falagas ME; Mavroudis AD; Vardakas KZ
    Expert Rev Anti Infect Ther; 2016 Aug; 14(8):747-63. PubMed ID: 27400643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Loeb M; Brooks AA
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Will new antimicrobials overcome resistance among Gram-negatives?
    Bassetti M; Ginocchio F; Mikulska M; Taramasso L; Giacobbe DR
    Expert Rev Anti Infect Ther; 2011 Oct; 9(10):909-22. PubMed ID: 21973303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infections by multidrug-resistant Gram-negative Bacteria: What's new in our arsenal and what's in the pipeline?
    Koulenti D; Song A; Ellingboe A; Abdul-Aziz MH; Harris P; Gavey E; Lipman J
    Int J Antimicrob Agents; 2019 Mar; 53(3):211-224. PubMed ID: 30394301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic adjuvants: an alternative approach to overcome multi-drug resistant Gram-negative bacteria.
    Liu Y; Li R; Xiao X; Wang Z
    Crit Rev Microbiol; 2019 May; 45(3):301-314. PubMed ID: 30985240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Antibiotics in the Treatment of Urinary Tract Infections.
    Naber KG; Wagenlehner FME
    Eur Urol Focus; 2019 Jan; 5(1):10-12. PubMed ID: 30555037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emergence and implications of metallo-beta-lactamases in Gram-negative bacteria.
    Walsh TR
    Clin Microbiol Infect; 2005 Nov; 11 Suppl 6():2-9. PubMed ID: 16209700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fight Against Antimicrobial Resistance: We Always Need New Antibacterials but for Right Bacteria.
    Duval RE; Grare M; Demoré B
    Molecules; 2019 Aug; 24(17):. PubMed ID: 31470632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to beta-lactams in Gram-negative bacilli: relevance and potential therapeutic alternatives.
    Garcia-Bustos V; Cabañero-Navalón MD; Salavert Lletí M
    Rev Esp Quimioter; 2022 Sep; 35 Suppl 2(Suppl 2):1-15. PubMed ID: 36193979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New β-lactamase inhibitors: a therapeutic renaissance in an MDR world.
    Drawz SM; Papp-Wallace KM; Bonomo RA
    Antimicrob Agents Chemother; 2014; 58(4):1835-46. PubMed ID: 24379206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial Resistance in the Intensive Care Unit: A Focus on Gram-Negative Bacterial Infections.
    MacVane SH
    J Intensive Care Med; 2017 Jan; 32(1):25-37. PubMed ID: 26772199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftazidime-Avibactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination for the Treatment of Resistant Gram-negative Organisms.
    Sharma R; Park TE; Moy S
    Clin Ther; 2016 Mar; 38(3):431-44. PubMed ID: 26948862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.